Race is a Contributing Factor to Clinico-Pathological Characteristics of Ameloblastoma at a Multi-Network Academic Hospital System

Ameloblastoma is an odontogenic tumor with an aggressive growth pattern and high recurrence rate. Impact of race and geographic location on clinico-pathological characteristics of ameloblastoma is unclear. The study objective was to assess race-dependent clinico-pathological characteristics and treatment approaches for ameloblastoma at a hospital network of an academic institution located in a racially diverse metropolitan city. Retrospective analysis of ameloblastoma patient records spanning 15 years from 2009 to 2024 was performed. Data extracted included patient demographic profile, clinical, radiologic, histologic, and treatment information. Data analysis assessed the association between race, clinical, histological, and radiological features of ameloblastoma, as well as treatment approaches. Median age of a total of 64 ameloblastoma patients was 44 years. African American patients were significantly younger, under 21 years of age, than non-African American patients (p = 0.004). Mandible, especially posterior region, was the most affected anatomic site (78.1%). Conventional ameloblastoma (72.3%) was the most common histologic type, but unicystic ameloblastoma was the most common in young individuals (p = 0.004) and African Americans. Jaw resection with reconstruction was the primary modality of treatment (75.4%), especially for conventional type, while most unicystic lesions were treated by enucleation and curettage. Ameloblastoma tumor volume was relatively larger in the following groups: males, African Americans, young patients, conventional histologic type, and unilocular radiographic lesions, which directly guided the decision to treat by surgical resection (p = 0.0001). There were no significant racial differences in presentation-time-to-treatment. Ameloblastoma developed at a young age, grew faster and larger in African American patients. Presentation-time-to-treatment and management approaches were not influenced by race.

Authors

Institutions

Publication Details

Journal
Journal of Racial and Ethnic Health Disparities
Published
2026-01-08
DOI
https://doi.org/10.1007/s40615-025-02842-7
Primary Topic
Oral and Maxillofacial Pathology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Race is a Contributing Factor to Clinico-Pathological Characteristics of Ameloblastoma at a Multi-Network Academic Hospital System

Sunday O. Akintoye, John J. Thompson, Lee Carrasco, Taha Ghouleh et al.
Journal of Racial and Ethnic Health Disparities
Oral and Maxillofacial Pathology
article

Race is a Contributing Factor to Clinico-Pathological Characteristics of Ameloblastoma at a Multi-Network Academic Hospital System

Sunday O. Akintoye, John J. Thompson, Lee Carrasco, Taha Ghouleh, Austin Baker, Abdul Warith O. Akinshipo
article en

Abstract

Ameloblastoma is an odontogenic tumor with an aggressive growth pattern and high recurrence rate. Impact of race and geographic location on clinico-pathological characteristics of ameloblastoma is unclear. The study objective was to assess race-dependent clinico-pathological characteristics and treatment approaches for ameloblastoma at a hospital network of an academic institution located in a racially diverse metropolitan city. Retrospective analysis of ameloblastoma patient records spanning 15 years from 2009 to 2024 was performed. Data extracted included patient demographic profile, clinical, radiologic, histologic, and treatment information. Data analysis assessed the association between race, clinical, histological, and radiological features of ameloblastoma, as well as treatment approaches. Median age of a total of 64 ameloblastoma patients was 44 years. African American patients were significantly younger, under 21 years of age, than non-African American patients (p = 0.004). Mandible, especially posterior region, was the most affected anatomic site (78.1%). Conventional ameloblastoma (72.3%) was the most common histologic type, but unicystic ameloblastoma was the most common in young individuals (p = 0.004) and African Americans. Jaw resection with reconstruction was the primary modality of treatment (75.4%), especially for conventional type, while most unicystic lesions were treated by enucleation and curettage. Ameloblastoma tumor volume was relatively larger in the following groups: males, African Americans, young patients, conventional histologic type, and unilocular radiographic lesions, which directly guided the decision to treat by surgical resection (p = 0.0001). There were no significant racial differences in presentation-time-to-treatment. Ameloblastoma developed at a young age, grew faster and larger in African American patients. Presentation-time-to-treatment and management approaches were not influenced by race.

Journal of Racial and Ethnic Health Disparities
University of Lagos (NG), National Medical Research Center of Dentistry and Maxillofacial Surgery (RU), University of Pennsylvania (US), Philadelphia University (US)
U.S. Department of Health and Human Services, National Institutes of Health
Openalex Percentile: Top 92%
Oral and Maxillofacial Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.